Global Whole Exome Sequencing Market 2023
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
$2,600.00
According to market research study published by Gen Consulting Company, the market size of the global therapeutic biologics sector is expected to rise by USD 170 billion with a CAGR of 7.7% by the end of 2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global therapeutic biologics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the therapeutic biologics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, and region. The global market for therapeutic biologics can be segmented by product: therapeutic proteins, vaccines, others. The therapeutic proteins segment was the largest contributor to the global therapeutic biologics market in 2021. Therapeutic biologics market is further segmented by region: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. According to the research, North America had the largest share in the global therapeutic biologics market.
By product:
– therapeutic proteins
– vaccines
– others
By region:
– Asia Pacific
– Europe
– North America
– MEA (Middle East and Africa)
– Latin America
The report explores the recent developments and profiles of key vendors in the Global Therapeutic Biologics Market, including Amgen Inc., Baxter International Inc., China Biologic Products Holdings, Inc., CSL Ltd., Eli Lilly and Company, GlaxoSmithKline plc (GSK plc), Grifols, S.A., Kedrion S.p.A., Novartis AG, Octapharma AG, Reliance Life Sciences, Roche Holding AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global therapeutic biologics market.
– To classify and forecast the global therapeutic biologics market based on product, region.
– To identify drivers and challenges for the global therapeutic biologics market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global therapeutic biologics market.
– To identify and analyze the profile of leading players operating in the global therapeutic biologics market.
Why Choose This Report
– Gain a reliable outlook of the global therapeutic biologics market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· Therapeutic proteins
· Vaccines
· Others
PART 6. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· MEA (Middle East and Africa)
· Latin America
PART 7. KEY COMPANIES
· Amgen Inc.
· Baxter International Inc.
· China Biologic Products Holdings, Inc.
· CSL Ltd.
· Eli Lilly and Company
· GlaxoSmithKline plc (GSK plc)
· Grifols, S.A.
· Kedrion S.p.A.
· Novartis AG
· Octapharma AG
· Reliance Life Sciences
· Roche Holding AG
· Sanofi S.A.
· Teva Pharmaceutical Industries Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Amgen Inc.
Baxter International Inc.
China Biologic Products Holdings, Inc.
CSL Ltd.
Eli Lilly and Company
GlaxoSmithKline plc (GSK plc)
Grifols, S.A.
Kedrion S.p.A.
Novartis AG
Octapharma AG
Reliance Life Sciences
Roche Holding AG
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2021 |
Forecast Year | 2022-2028 |
CAGR (2022-2028) | 7.7% |
Pages | 86 |
Key Players | Amgen Inc., Baxter International Inc., China Biologic Products Holdings Inc., CSL Ltd., Eli Lilly and Company, GlaxoSmithKline plc (GSK plc), Grifols S.A., Kedrion S.p.A., Novartis AG, Octapharma AG, Reliance Life Sciences, Roche Holding AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd. |
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global continuous bioprocessing market, in terms of revenue, is expected to grow by 17.9 percent annually through 2029, according to the latest estimates. The top market companies profiles included…
The global virology testing market is projected to expand at a CAGR of ~1.2 percent across the forecast period of 2023 – 2029, according to the latest edition of the…
Please fill out our form and we will get back to you.